Biofrontera Inc. BFRI 深 沪
等待开盘 05-15 09:30:00 美东时间
0.985
+0.025
+2.63%
华盛通- 最 高1.02
- 今 开0.88
- 成交量 35.79万股
- 最 低 0.88
- 昨 收 0.9598
- 总市值 1182.74万
- 52周最高 1.19
- 市盈率 静 --
- 换手率 2.98%
- 52周最低 0.536
- 委 比 -99.74%
- 总股本 1200.76万
- 历史最高 292.60
- 量 比 2.55
- 振 幅 14.59%
- 历史最低 0.536
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Transcript: Biofrontera Q1 2026 Earnings Conference Call
On Thursday, Biofrontera (NASDAQ:BFRI) discussed first-quarter financial result...
59分钟前
Biofrontera Q1 EPS $(0.41) Misses $(0.12) Estimate, Sales $10.084M Miss $10.250M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.12) by 272.73 percent. This is a 12.77 percent increase over losses of $(0.47) per share from
05-14 20:08
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
Biofrontera Inc. will report its Q1 2026 financial results on May 14, 2026, after U.S. markets close. A conference call at 11:00 a.m. ET on the same day will discuss the results, provide a business update, and answer questions. The call can be accessed via 1-877-877-1275 (U.S./Canada) or 1-412-858-5202 (international), with a webcast available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Re1hZKm0. Biofrontera specializes in p...
05-08 20:00
电话会总结 ｜ Biofrontera(BFRI)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Biofrontera业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **季度表现（2025年Q4）：** - 营收达到1,710万美元，创公司历史新高，同比增长36% - 净利润560万美元，较上年同期140万美元净亏损实现扭亏为盈 - 调整后EBITDA为490万美元，较上年同期负140万美元大幅改善630万美元 - 毛利率提升至82%，较上年同期58%显著改善 **全年表现（2025年）：** - 年度营收4,170万美元，同比增长12% - 净亏损1,050万美元，较上年1,780万美元净亏损改善41% - 调整后EBITDA
03-20 12:31
Biofrontera Earnings Call: Profits Rise, Risks Remain
Biofrontera, Inc. (($BFRI)) has held its Q4 earnings call. Read on for the main...
03-20 08:09
Biofrontera Q4 EPS $0.48 Beats $0.20 Estimate, Sales $17.100M Beat $16.146M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.20 by 146.15 percent. This is a 352.63 percent increase over losses of $(0.19) per share from the
03-20 05:49
Biofrontera reports rise in Q4 revenue, turns profitable
Biofrontera (BFRI) reported record Q4 2025 revenue of $17.1M, up 36% year-over-year. Gross margin surged to 82.4%, driven by improved cost structure after its transaction with Biofrontera AG. The comp...
03-20 03:18
Dermatology drugmaker Biofrontera's Q4 revenue rises to record high on Ameluz strength
Dermatology drugmaker Biofrontera's Q4 revenue rises to record high on Ameluz strength Overview US biopharma firm's Q4 revenue rose 36% yr/yr to record high, driven by Ameluz sales Company posted Q4 net income of $5.6 mln, reversing prior-year loss Gross margin improved to 82.4% in Q4, reflecting lo
03-19 21:36
BRIEF-Biofrontera Q4 Revenue USD 17.1 Million
BRIEF-Biofrontera Q4 Revenue USD 17.1 Million Mar 19 (Reuters) - Biofrontera Q4 net income USD 5.6 million. Q4 adjusted EBITDA USD 4.9 million Q4 operating expenses USD 12.5 million
03-19 21:25
